Catalyst Wire Dossier Catalyst Wire Dossier

Chemotherapy (low-intensity or standard-of-care)

low-intensity chemotherapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Chemotherapy (low-intensity or standard-of-care), covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia [Phase 3]

See pricing